Amlodipine, hydrochlorothiazide, valsartan
Sold as Co exforge, Co- copalia, Co-copalia, Diptatris, Mavatris, Chlovamal, Arlozyb co, Kyrilok, Amvaltri, Amvaltri registration, Calsar co, Gemvalaz co, Valgamez co
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Background
Registration
- Applicants
- 7
- Registrations
- 54
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Novartis South Africa (Pty) Ltd | Co exforge, Co- copalia, Co-copalia | 5 mg/160 mg/12,5 mg, 5 mg/160 mg/25 mg, 5/160/12,5mg, 5/160/25mg, 10 mg/160 mg/12,5 mg, 10 mg/160 mg/25 mg, 10 mg/320 mg/25 mg, 10/160/25 mg, 10/320/25 mg | 440075, 440076, 440077, 440078, 440079, 480872, 480873, 480875, 480876 | S3 | None |
| Viatris Healthcare (Pty) Ltd | Diptatris, Mavatris, Chlovamal | 5 mg/160 mg/ 12,5 mg, 5 mg/160 mg/ 25 mg, 5 mg/160 mg/12,5 mg, 5 mg/160 mg/25 mg, 10 mg/160 mg/ 25 mg, 10 mg/320 mg/25 mg, 10 mg/160 mg/ 12,5 mg, 10 mg/160 mg/25 mg, 10 mg/160 mg/12,5 mg | 56/7.1.3/0003, 560004, 560005, 560006, 560007, 560008.003, 560009.004, 560010.005, 560011.006, 560012.007, 560013.003, 560014.004, 560015.005, 560016.006, 560017.0007 | S3 | None |
| Macleods Pharmaceuticals SA (Pty) Ltd | Arlozyb co, Kyrilok | 5/160/12,5 mg, 5/160/25 mg, 10/160/12,5 mg, 10/160/25 mg, 10/320/25 mg | 560560, 560561, 560562, 560563, 560564, 560565.560, 560566.561, 560567.562, 560568.563, 560569.564 | S3 | None |
| Unicorn Pharmaceuticals (Pty) Ltd | Amvaltri, Amvaltri registration | 5 mg/160 mg/12,5 mg, 5 mg/160 mg/25 mg, 10 mg/160 mg/12,5 mg, 10 mg/160 mg/25 mg, 10 mg/320 mg/25 mg 2 | 560730, 560731, 560732, 560733, 560734 | S3 | None |
| Pharma Dynamics (Pty) Ltd | Calsar co | 5/160/12,5 mg, 5/160/25 mg, 10/160/12,5 mg, 101/160/25 mg, 101/320/25 mg | 570101, 570102, 570103, 570104, 570105 | S3 | None |
| Ranbaxy Pharmaceutical (Pty) LtdCancelled | Gemvalaz co, Valgamez co | 5/160/12,5 mg, 5/160/25 mg, 10/160/12,5 mg, 10/160/25 mg, 10/320/25 mg | 570306, 570307, 570308, 570309, 570310, 570311.306, 570313.308, 570314.309, 570315.310 | S3 | None |
| Ranbaxy (SA) (Pty) LtdCancelled | Valgamez co | 10/160/12,5 mg | 570312.307 | S3 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Co exforge 5 mg/160 mg/12,5 MG EACH TABLET CONTAINS: AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 5,0 mg, VALSARTAN 160,0 mg ,HYDROCHLOROTHIAZIDE 12,5 mg | 5 mg/160 mg/12,5 mg | 44007544/7.1.3/0075 | Registered | S3 | None |
| Co exforge 5 mg/160 mg/25 MG EACH TABLET CONTAINS: AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 5,0 mg ,VALSARTAN 160,0 mg, HYDROCHLOROTHIAZIDE 25,0 mg | 5 mg/160 mg/25 mg | 44007644/7.1.3/0076 | Registered | S3 | None |
| Co exforge 10 mg/160 mg/12,5 MG EACH TABLET CONTAINS: AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg ,VALSARTAN 160,0 mg ,HYDROCHLOROTHIAZIDE 12,5 mg | 10 mg/160 mg/12,5 mg | 44007744/7.1.3/0077 | Registered | S3 | None |
| Co exforge 10 mg/160 mg/25 MG EACH TABLET CONTAINS: AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 25,0 mg | 10 mg/160 mg/25 mg | 44007844/7.1.3/0078 | Registered | S3 | None |
| Co exforge 10 mg/320 mg/25 MG EACH TABLET CONTAINS: AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg, VALSARTAN 320,0 mg, HYDROCHLOROTHIAZIDE 25,0 mg | 10 mg/320 mg/25 mg | 44007944/7.1.3/0079 | Registered | S3 | None |
| Co- copalia 5/160/12,5mg EACH TABLET CONTAINS: AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 5,0 mg ,VALSARTAN 160,0 mg ,HYDROCHLOROTHIAZIDE 12,5 mg | 5/160/12,5mg | 48087248/7.1.3/0872 | Registered | S3 | None |
| Co- copalia 5/160/25mg EACH TABLET CONTAINS: AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 5,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 25,0 mg | 5/160/25mg | 48087348/7.1.3/0873 | Registered | S3 | None |
| Co- copalia 10/160/25 MG EACH TABLET CONTAINS: AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 25,0 mg | 10/160/25 mg | 48087548/7.1.3/0875 | Registered | S3 | None |
| Co-copalia10/320/25 MG EACH TABLET CONTAINS: AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 320,0 mg HYDROCHLOROTHIAZIDE 25,0 mg | 10/320/25 mg | 48087648/7.1.3/0876 | Registered | S3 | None |
| Diptatris 5 mg/160 mg/ 12,5 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 5,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 12,5 mg | 5 mg/160 mg/ 12,5 mg | 56/7.1.3/0003560003 | Registered | S3 | None |
| Diptatris 5 mg/160 mg/ 25 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 5,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 25,0 mg | 5 mg/160 mg/ 25 mg | 56000456/7.1.3/0004 | Registered | S3 | None |
| Diptatris 10 mg/160 mg/ 25 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 25,0 mg | 10 mg/160 mg/ 25 mg | 56000556/7.1.3/0005 | Registered | S3 | None |
| Diptatris 10 mg/320 mg/25 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 320,0 mg HYDROCHLOROTHIAZIDE 25,0 mg | 10 mg/320 mg/25 mg | 56000656/7.1.3/0006 | Registered | S3 | None |
| Diptatris 10 mg/160 mg/ 12,5 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 12,5 mg | 10 mg/160 mg/ 12,5 mg | 56000756/7.1.3/0007 | Registered | S3 | None |
| Mavatris 5 mg/160 mg/12,5 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 5,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 12,5 mg | 5 mg/160 mg/12,5 mg | 560008.00356/7.1.3/0008.003 | Registered | S3 | None |
| Mavatris 5 mg/160 mg/25 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 5,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 25,0 mg | 5 mg/160 mg/25 mg | 560009.00456/7.1.3/0009.004 | Registered | S3 | None |
| Mavatris 10 mg/160 mg/25 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 25,0 mg | 10 mg/160 mg/25 mg | 560010.00556/7.1.3/0010.005 | Registered | S3 | None |
| Mavatris 10 mg/320 mg/25 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 320,0 mg HYDROCHLOROTHIAZIDE 25,0 mg | 10 mg/320 mg/25 mg | 560011.00656/7.1.3/0011.006 | Registered | S3 | None |
| Mavatris 10 mg/160 mg/12,5 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 12,5 mg | 10 mg/160 mg/12,5 mg | 560012.00756/7.1.3/0012.007 | Registered | S3 | None |
| Chlovamal 5 mg/160 mg/12,5 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 5,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 12,5 mg | 5 mg/160 mg/12,5 mg | 560013.00356/7.1.3/0013.003 | Registered | S3 | None |
| Chlovamal 5 mg/160 mg/25 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 5,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 25,0 mg | 5 mg/160 mg/25 mg | 560014.00456/7.1.3/0014.004 | Registered | S3 | None |
| Chlovamal 10 mg/160 mg/25 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 25,0 mg | 10 mg/160 mg/25 mg | 560015.00556/7.1.3/0015.005 | Registered | S3 | None |
| Chlovamal 10 mg/320 mg/25 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 320,0 mg HYDROCHLOROTHIAZIDE 25,0 mg | 10 mg/320 mg/25 mg | 560016.00656/7.1.3/0016.006 | Registered | S3 | None |
| Chlovamal10 mg/160 mg/12,5 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 12,5 mg | 10 mg/160 mg/12,5 mg | 560017.000756/7.1.3/0017.007 | Registered | S3 | None |
| Arlozyb co tablets 5/160/12,5 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 5,0 mg , VALSARTAN 160,0 mg, HYDROCHLOROTHIAZIDE 12,5 mg | 5/160/12,5 mgTablets | 56056056/7.1.3/0560 | Registered | S3 | None |
| Arlozyb co tablets 5/160/25 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 5,0 mg , VALSARTAN 160,0 mg, HYDROCHLOROTHIAZIDE 25,0 mg | 5/160/25 mgTablets | 56056156/7.1.3/0561 | Registered | S3 | None |
| Arlozyb co tablets 10/160/12,5 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg ,VALSARTAN 160,0 mg, HYDROCHLOROTHIAZIDE 12,5 mg | 10/160/12,5 mgTablets | 56056256/7.1.3/0562 | Registered | S3 | None |
| Arlozyb co tablets 10/160/25 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg ,VALSARTAN 160,0 mg, HYDROCHLOROTHIAZIDE 25,0 mg | 10/160/25 mgTablets | 56056356/7.1.3/0563 | Registered | S3 | None |
| Arlozyb co tablets 10/320/25 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg ,VALSARTAN 320,0 mg, HYDROCHLOROTHIAZIDE 25,0 mg | 10/320/25 mgTablets | 56056456/7.1.3/0564 | Registered | S3 | None |
| Kyrilok tablets 5/160/12,5 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 5,0 mg , VALSARTAN 160,0 mg, HYDROCHLOROTHIAZIDE 12,5 mg | 5/160/12,5 mgTablets | 560565.56056/7.1.3/0565.560 | Registered | S3 | None |
| Kyrilok tablets 5/160/25 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 5,0 mg ,VALSARTAN 160,0 mg, HYDROCHLOROTHIAZIDE 25,0 mg | 5/160/25 mgTablets | 560566.56156/7.1.3/0566.561 | Registered | S3 | None |
| Kyrilok tablets 10/160/12,5 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg ,VALSARTAN 160,0 mg, HYDROCHLOROTHIAZIDE 12,5 mg | 10/160/12,5 mgTablets | 560567.56256/7.1.3/0567.562 | Registered | S3 | None |
| Kyrilok tablets 10/160/25 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 160,0 mg, HYDROCHLOROTHIAZIDE 25,0 mg | 10/160/25 mgTablets | 560568.56356/7.1.3/0568.563 | Registered | S3 | None |
| Kyrilok tablets 10/320/25 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg ,VALSARTAN 320,0 mg, HYDROCHLOROTHIAZIDE 25,0 mg | 10/320/25 mgTablets | 560569.56456/7.1.3/0569.564 | Registered | S3 | None |
| Amvaltri 5 mg/160 mg/12,5 MG EACH TABLET CONTAINS: AMLODIPINE BESILATE EQUIVALENT TO AMLODIPINE 5,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 12,5 mg | 5 mg/160 mg/12,5 mg | 56073056/7.1.3/0730 | Registered | S3 | None |
| Amvaltri 5 mg/160 mg/25 MG EACH TABLET CONTAINS: AMLODIPINE BESILATE EQUIVALENT TO AMLODIPINE 5,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 25,0 mg | 5 mg/160 mg/25 mg | 56073156/7.1.3/0731 | Registered | S3 | None |
| Amvaltri 10 mg/160 mg/12,5 MG EACH TABLET CONTAINS: AMLODIPINE BESILATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 12,5 mg | 10 mg/160 mg/12,5 mg | 56073256/7.1.3/0732 | Registered | S3 | None |
| Amvaltri 10 mg/160 mg/25 MG EACH TABLET CONTAINS: AMLODIPINE BESILATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 25,0 mg | 10 mg/160 mg/25 mg | 56073356/7.1.3/0733 | Registered | S3 | None |
| Amvaltri 10 mg/320 mg/25 MG 2. Registration EACH TABLET CONTAINS: AMLODIPINE BESILATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 320,0 mg HYDROCHLOROTHIAZIDE 25,0 mg | 10 mg/320 mg/25 mg 2. | 56073456/7.1.3/0734 | Registered | S3 | None |
| Calsar co 5/160/12,5 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 5,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 12,5 mg | 5/160/12,5 mg | 57010157/7.1.3/0101 | Registered | S3 | None |
| Calsar co 10/160/12,5 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 12,5 mg | 10/160/12,5 mg | 57010257/7.1.3/0102 | Registered | S3 | None |
| Calsar co 5/160/25 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 5,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 25,0 mg | 5/160/25 mg | 57010357/7.1.3/0103 | Registered | S3 | None |
| Calsar co 101/160/25 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 25,0 mg | 101/160/25 mg | 57010457/7.1.3/0104 | Registered | S3 | None |
| Calsar co 101/320/25 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 320,0 mg HYDROCHLOROTHIAZIDE 25,0 mg | 101/320/25 mg | 57010557/7.1.3/0105 | Registered | S3 | None |
| Gemvalaz co 5/160/12,5 MG EACH TABLET CONTAINS: AMLODIPINE BESILATE EQUIVALENT TO AMLODIPINE 5,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 12,5 mg | 5/160/12,5 mg | 57030657/7.1.3/0306 | Cancelled | S3 | None |
| Gemvalaz co 10/160/12,5 MG EACH TABLET CONTAINS: AMLODIPINE BESILATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 12,5 mg | 10/160/12,5 mg | 57030757/7.1.3/0307 | Cancelled | S3 | None |
| Gemvalaz co 5/160/25 MG EACH TABLET CONTAINS: AMLODIPINE BESILATE EQUIVALENT TO AMLODIPINE 5,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 25 mg | 5/160/25 mg | 57030857/7.1.3/0308 | Cancelled | S3 | None |
| Gemvalaz co 10/160/25 MG EACH TABLET CONTAINS:AMLODIPINE BESILATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 25 mg | 10/160/25 mg | 57030957/7.1.3/0309 | Cancelled | S3 | None |
| Gemvalaz co 10/320/25 MG EACH TABLET CONTAINS: AMLODIPINE BESILATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 320,0 mg HYDROCHLOROTHIAZIDE 25,0 mg | 10/320/25 mg | 57031057/7.1.3/0310 | Cancelled | S3 | None |
| Valgamez co 5/160/12,5 MG EACH TABLET CONTAINS: AMLODIPINE BESILATE EQUIVALENT TO AMLODIPINE 5,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 12,5 mg | 5/160/12,5 mg | 570311.30657/7.1.3/0311.306 | Cancelled | S3 | None |
| Valgamez co 10/160/12,5 MG EACH TABLET CONTAINS AMLODIPINE BESILATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 12,5 mg | 10/160/12,5 mg | 570312.30757/7.1.3/0312.307 | Cancelled | S3 | None |
| Valgamez co 5/160/25 MG EACH TABLET CONTAINS AMLODIPINE BESILATE EQUIVALENT TO AMLODIPINE 5,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 25,0 mg | 5/160/25 mg | 570313.30857/7.1.3/0313.308 | Cancelled | S3 | None |
| Valgamez co 10/160/25 MG EACH TABLET CONTAINS AMLODIPINE BESILATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 160,0 mg HYDROCHLOROTHIAZIDE 25 mg | 10/160/25 mg | 570314.30957/7.1.3/0314.309 | Cancelled | S3 | None |
| Valgamez co 10/320/25 MG EACH TABLET CONTAINS AMLODIPINE BESILATE EQUIVALENT TO AMLODIPINE 10,0 mg VALSARTAN 320,0 mg HYDROCHLOROTHIAZIDE 25,0 mg | 10/320/25 mg | 570315.31057/7.1.3/0315.310 | Cancelled | S3 | None |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, matched to the Consolidated Schedules by ingredient, confidence medium.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Amlodipine besylate equivalent to amlodipine, valsartan, hydrochlorothiazide
S3: Amlodipine
Consolidated Schedules 06 July 2026, line 3138
S3: Hydrochlorothiazide
Consolidated Schedules 06 July 2026, line 3721
S3: Valsartan
Consolidated Schedules 06 July 2026, line 4376
Pharmacological class: Other hypotensives. (class 7.1.3)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.